Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neurocrine Bioscienc (NBIX)

Neurocrine Bioscienc (NBIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,236,826
  • Shares Outstanding, K 95,577
  • Annual Sales, $ 1,134 M
  • Annual Income, $ 89,600 K
  • 60-Month Beta 0.70
  • Price/Sales 7.20
  • Price/Cash Flow 68.75
  • Price/Book 5.87
Trade NBIX with:

Options Overview Details

View History
  • Implied Volatility 42.13% ( +3.03%)
  • Historical Volatility 39.78%
  • IV Percentile 51%
  • IV Rank 27.80%
  • IV High 68.76% on 01/26/22
  • IV Low 31.88% on 05/26/21
  • Put/Call Vol Ratio 0.17
  • Today's Volume 35
  • Volume Avg (30-Day) 723
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 13,180
  • Open Int (30-Day) 27,269

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.55
  • Number of Estimates 11
  • High Estimate 0.82
  • Low Estimate 0.33
  • Prior Year 0.43
  • Growth Rate Est. (year over year) +27.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.25 +14.94%
on 05/09/22
93.86 -7.85%
on 04/26/22
-7.13 (-7.62%)
since 04/22/22
3-Month
75.25 +14.94%
on 05/09/22
100.73 -14.14%
on 04/08/22
+0.94 (+1.10%)
since 02/23/22
52-Week
71.88 +20.33%
on 01/10/22
108.01 -19.93%
on 11/01/21
-9.48 (-9.88%)
since 05/21/21

Most Recent Stories

More News
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Sector ETF report for FBT

FBT : 134.17 (+0.55%)
EXEL : 17.75 (-0.06%)
IBB : 116.44 (+0.72%)
NBIX : 86.49 (+0.36%)
SRPT : 71.61 (+0.67%)
XBI : 70.14 (-0.27%)
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Smart Beta ETF report for FBT

FBT : 134.17 (+0.55%)
EXEL : 17.75 (-0.06%)
IBB : 116.44 (+0.72%)
NBIX : 86.49 (+0.36%)
SRPT : 71.61 (+0.67%)
XBI : 70.14 (-0.27%)
Neurocrine Biosciences (NBIX) Q1 2022 Earnings Call Transcript

NBIX earnings call for the period ending March 31, 2022.

NBIX : 86.49 (+0.36%)
Neurocrine Biosciences (NBIX) Lags Q1 Earnings Estimates

Neurocrine (NBIX) delivered earnings and revenue surprises of -57.58% and 1.97%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

NBIX : 86.49 (+0.36%)
TARO : 36.55 (-2.79%)
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Sector ETF report for FBT

FBT : 134.17 (+0.55%)
IBB : 116.44 (+0.72%)
NBIX : 86.49 (+0.36%)
SRPT : 71.61 (+0.67%)
ACAD : 16.79 (-1.87%)
XBI : 70.14 (-0.27%)
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Smart Beta ETF report for FBT

FBT : 134.17 (+0.55%)
IBB : 116.44 (+0.72%)
NBIX : 86.49 (+0.36%)
SRPT : 71.61 (+0.67%)
ACAD : 16.79 (-1.87%)
XBI : 70.14 (-0.27%)
NVIDIA and Neurocrine Biosciences highlighted as Zacks Bull and Bear of the Day

NVIDIA and Neurocrine Biosciences highlighted as Zacks Bull and Bear of the Day.

HAL : 38.33 (+4.44%)
MRO : 28.13 (+3.19%)
OXY : 65.42 (+3.41%)
NVDA : 168.98 (+1.22%)
NBIX : 86.49 (+0.36%)
Bear of the Day: Neurocrine Biosciences (NBIX)

Strong growth for Ingrezza meets company investment in the pipeline, sparking lowered EPS estimates

NBIX : 86.49 (+0.36%)
Neurocrine: Q4 Earnings Snapshot

SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Friday reported a fourth-quarter loss of $7.3 million, after reporting a profit in the same period a year earlier.

NBIX : 86.49 (+0.36%)
Neurocrine Biosciences (NBIX) Q4 2021 Earnings Call Transcript

NBIX earnings call for the period ending December 31, 2021.

NBIX : 86.49 (+0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding...

See More

Key Turning Points

3rd Resistance Point 89.71
2nd Resistance Point 88.66
1st Resistance Point 87.57
Last Price 86.49
1st Support Level 85.44
2nd Support Level 84.39
3rd Support Level 83.30

See More

52-Week High 108.01
Fibonacci 61.8% 94.21
Fibonacci 50% 89.94
Last Price 86.49
Fibonacci 38.2% 85.68
52-Week Low 71.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar